CN101827592A - 用可乐定治疗手术后效应诸如痉挛状态和战栗的方法 - Google Patents

用可乐定治疗手术后效应诸如痉挛状态和战栗的方法 Download PDF

Info

Publication number
CN101827592A
CN101827592A CN200980100804A CN200980100804A CN101827592A CN 101827592 A CN101827592 A CN 101827592A CN 200980100804 A CN200980100804 A CN 200980100804A CN 200980100804 A CN200980100804 A CN 200980100804A CN 101827592 A CN101827592 A CN 101827592A
Authority
CN
China
Prior art keywords
clonidine
durative action
action preparation
spasticity
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200980100804A
Other languages
English (en)
Chinese (zh)
Inventor
V·M·金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Warsaw Orthopedic Inc
Original Assignee
Medtronic Inc
Warsaw Orthopedic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc, Warsaw Orthopedic Inc filed Critical Medtronic Inc
Publication of CN101827592A publication Critical patent/CN101827592A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN200980100804A 2008-04-18 2009-04-17 用可乐定治疗手术后效应诸如痉挛状态和战栗的方法 Pending CN101827592A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4619208P 2008-04-18 2008-04-18
US61/046,192 2008-04-18
US12/408,491 US20090263443A1 (en) 2008-04-18 2009-03-20 Methods for treating post-operative effects such as spasticity and shivering with clondine
US12/408,491 2009-03-20
PCT/US2009/040885 WO2009129428A2 (en) 2008-04-18 2009-04-17 Methods for treating post-operative effects such as spasticity and shivering with clonidine

Publications (1)

Publication Number Publication Date
CN101827592A true CN101827592A (zh) 2010-09-08

Family

ID=41199746

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200980100804A Pending CN101827592A (zh) 2008-04-18 2009-04-17 用可乐定治疗手术后效应诸如痉挛状态和战栗的方法

Country Status (5)

Country Link
US (1) US20090263443A1 (de)
EP (1) EP2207545B1 (de)
JP (1) JP2011518787A (de)
CN (1) CN101827592A (de)
WO (1) WO2009129428A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
WO2012075451A2 (en) * 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Clonidine and gaba compounds in a biodegradable polymer carrier
WO2012075447A2 (en) * 2010-12-03 2012-06-07 Warsaw Orthopedic, Inc. Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
ES2960753T3 (es) * 2015-09-21 2024-03-06 Teva Pharmaceuticals Int Gmbh Formulaciones de olanzapina de liberación sostenida
JP2020511483A (ja) 2017-03-20 2020-04-16 テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーＴｅｖａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ ＧｍｂＨ 徐放性オランザピン製剤
EP3691618A1 (de) 2017-10-06 2020-08-12 Foundry Therapeutics, Inc. Implantierbare depots zur kontrollierten freisetzung therapeutischer wirkstoffe

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
CA2195119C (en) * 1995-06-09 2001-09-11 Mark Chasin Formulations and methods for providing prolonged local anesthesia
US6113624A (en) * 1995-10-02 2000-09-05 Ethicon, Inc. Absorbable elastomeric polymer
EP0949905B1 (de) * 1996-12-20 2001-07-18 Alza Corporation Injizierbare depotgelzubereitung und herstellungsverfahren
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy
CA2321004C (en) * 1998-05-12 2004-05-04 Scimed Life Systems, Inc. Manual bone anchor placement devices
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6927044B2 (en) * 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6436099B1 (en) * 1999-04-23 2002-08-20 Sdgi Holdings, Inc. Adjustable spinal tether
US7220281B2 (en) * 1999-08-18 2007-05-22 Intrinsic Therapeutics, Inc. Implant for reinforcing and annulus fibrosis
US7329529B2 (en) * 1999-09-03 2008-02-12 Millennium Pharmaceuticals, Inc. Ubiqutin proteases
US7951201B2 (en) * 1999-10-20 2011-05-31 Anulex Technologies, Inc. Method and apparatus for the treatment of the intervertebral disc annulus
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
WO2001045577A2 (en) * 1999-12-06 2001-06-28 Sdgi Holdings, Inc. Intervertebral disc treatment devices and methods
US6589549B2 (en) * 2000-04-27 2003-07-08 Macromed, Incorporated Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
EP1347741B1 (de) * 2001-01-03 2009-01-21 Bausch & Lomb Incorporated Wirkstoffabgabevorrichtungen mit verzögerter freisetzung mehrere stoffe enthaltend
US7229441B2 (en) * 2001-02-28 2007-06-12 Warsaw Orthopedic, Inc. Flexible systems for spinal stabilization and fixation
US8617048B2 (en) * 2001-03-09 2013-12-31 Boston Scientific Scimed, Inc. System for implanting an implant and method thereof
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
US6974462B2 (en) * 2001-12-19 2005-12-13 Boston Scientific Scimed, Inc. Surgical anchor implantation device
US8133501B2 (en) * 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US7345065B2 (en) * 2002-05-21 2008-03-18 Allergan, Inc. Methods and compositions for alleviating pain
US20040109893A1 (en) * 2002-06-25 2004-06-10 Guohua Chen Sustained release dosage forms of anesthetics for pain management
EP1531757B1 (de) * 2002-07-19 2016-09-07 Omeros Corporation Biologisch abbaubare triblock-copolymere, syntheseverfahren daf r und hydrogele und daraus hergestellte biologische materialien
US20040166088A1 (en) * 2003-01-15 2004-08-26 Shalaby Shalaby W. Polymeric precursors of non-absorbable, in situ-forming hydrogels and applications thereof
BRPI0410953A (pt) * 2003-05-30 2006-06-27 Alza Corp composições de depósito elastoméricas que podem ser implantadas, usos das mesmas e processo de produção
US7144412B2 (en) * 2003-06-25 2006-12-05 Wolf Medical Enterprises, Inc. Gold suture and method of use in wound closure
US20050058696A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
US20050059744A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
EP1691852A2 (de) * 2003-11-10 2006-08-23 Angiotech International AG Medizinsche implantate und fibroseinduzierende mittel
US20050175709A1 (en) * 2003-12-11 2005-08-11 Baty Ace M.Iii Therapeutic microparticles
JP2007519756A (ja) * 2004-01-30 2007-07-19 アンジオテック インターナショナル アーゲー 拘縮を治療するための組成物および方法
US7361168B2 (en) * 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US7410480B2 (en) * 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8512730B2 (en) * 2004-07-12 2013-08-20 Isto Technologies, Inc. Methods of tissue repair and compositions therefor
US20060046961A1 (en) * 2004-09-02 2006-03-02 Mckay William F Controlled and directed local delivery of anti-inflammatory compositions
US20060074422A1 (en) * 2004-09-27 2006-04-06 Story Brooks J Suture anchor and void filler combination
US20060253100A1 (en) * 2004-10-22 2006-11-09 Medtronic, Inc. Systems and Methods to Treat Pain Locally
AU2005309586A1 (en) * 2004-11-24 2006-06-01 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
US7611494B2 (en) * 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
US20060183786A1 (en) * 2005-02-16 2006-08-17 Chi Mei Foundation Hospital Injectable long-acting analgesic composition comprising an ester derivative of ketorolac
KR20120099730A (ko) * 2005-05-20 2012-09-11 오메로스 코포레이션 시클로옥시게나제 저해제 및 칼슘채널 길항제 조성물 및 이의 비뇨기과 시술시의 용도를 위한 방법
US7610100B2 (en) * 2005-12-30 2009-10-27 Boston Scientific Neuromodulation Corporation Methods and systems for treating osteoarthritis
US7741273B2 (en) * 2006-04-13 2010-06-22 Warsaw Orthopedic, Inc. Drug depot implant designs
US20070253994A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain
US20080021074A1 (en) * 2006-06-29 2008-01-24 Questcor Pharmaceuticals, Inc. Pharmaceutical Compositions and Related Methods of Treatment
US20080019970A1 (en) * 2006-07-07 2008-01-24 Gorman James R Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures
US20080091207A1 (en) * 2006-10-13 2008-04-17 Csaba Truckai Bone treatment systems and methods

Also Published As

Publication number Publication date
US20090263443A1 (en) 2009-10-22
EP2207545B1 (de) 2016-01-06
WO2009129428A3 (en) 2009-12-23
JP2011518787A (ja) 2011-06-30
EP2207545A2 (de) 2010-07-21
WO2009129428A2 (en) 2009-10-22
EP2207545A4 (de) 2012-02-15

Similar Documents

Publication Publication Date Title
US9861697B2 (en) Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
RU2510263C2 (ru) Способы и композиции, содержащие клонидин, предназначенные для лечения послеоперационной боли
US9700567B2 (en) Dexamethasone formulations in a biodegradable material
CN101854922A (zh) 用于减轻、预防或治疗疼痛和炎症的具有不同释放曲线的长效制剂
CN101951892A (zh) 使用氯压定和布比卡因治疗手术后疼痛的组合物和方法
JP5893061B2 (ja) 疼痛および／または炎症の治療のためのαアドレナリン作動性受容体アゴニスト
CN101969939B (zh) 用于治疗炎性疾病的α-肾上腺素能受体激动剂
CN101842099A (zh) 包括局部麻醉药的治疗术后痛的方法和组合物
CN101820876A (zh) 联合液体制剂用配制的药物贮存库治疗急性疼痛的方法
CN101827592A (zh) 用可乐定治疗手术后效应诸如痉挛状态和战栗的方法
CN104997722A (zh) 生物可降解聚合物载体中的可乐定制剂
CN101842086A (zh) α肾上腺素能受体激动剂用于治疗退行性椎间盘疾病
CN101835465A (zh) 生物可降解物质中的舒林酸制剂
AU2015203047A1 (en) Method for treating acute pain with a formulated drug depot in combination with a liquid formulation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100908